HDFC Bank Ltd Share Price Today - Live Blog for February 27, 2026

Sun Pharmaceutical Industries Ltd's share price has fallen by -3.57%, presenting both challenges and opportunities for investors. As of now, it's trading at 1655.80, and market participants are assessing the implications. The stock has a PE ratio of 37.6200, an ROE of 14.8407 and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd share price has declined by -3.79%, and it's currently trading at 1652.00. The stock maintains a PE of 37.6200, while the industry PE is 31.7721, prompting discussions about its valuation.

With a -3.79% decrease, Sun Pharmaceutical Industries Ltd's share price is now 1652.00. Investors should examine the factors driving this decline. The stock's PE ratio is 37.6200, whereas the industry PE ratio stands at 31.7721.

Sun Pharmaceutical Industries Ltd's share price has dropped by -3.92%, a development that warrants careful analysis. Presently trading at 1649.80, investors are assessing whether this presents an opportunity or a risk.

The share price of Sun Pharmaceutical Industries Ltd experienced a -3.92% slump and is currently trading at 1649.80. While the stock maintains a PE ratio of 37.6200, the industry PE is 31.7721, raising questions about valuation.

With a -4.99% decrease, Sun Pharmaceutical Industries Ltd's share price is now at 1631.50. The stock is currently trading at a PE of 37.6200, while the industry PE is 31.7721, prompting investors to assess its value proposition.

The stock of Sun Pharmaceutical Industries Ltd is facing a -4.99% decline and is currently trading at 1631.50 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Sun Pharmaceutical Industries Ltd stock price decreased by -4.49%, with the current market value at 1640.00 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Sun Pharmaceutical Industries Ltd is facing a -4.49% decline and is currently trading at 1640.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Sun Pharmaceutical Industries Ltd witnessed a -3.52% decrease in its share price, and it is currently trading at 1656.70. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.6200, an ROE of 14.8407 and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd's share price has fallen by -3.52%, a situation worth noting. At present, the stock is trading at 1656.70. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 37.6200, while the industry PE ratio is 31.7721.